Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 946 AL 960

The Potential Application of Mitochondrial Medicine in Toxicologic Poisoning

Jang DH, Lampe JW, Becker LB.

J Med Toxicol. 2015 Jun;11(2):201-7. doi: 10.1007/s13181-015-0478-8.

Animal models for prion-like diseases

Fernández-Borges N, Eraña H, Venegas V, Elezgarai SR, Harrathi C, Castilla J.

Virus Res. 2015 Sep 2;207:5-24. doi: 10.1016/j.virusres.2015.04.014. Epub 2015 Apr 20.

Neurologic Manifestations of Chronic Liver Disease and Liver Cirrhosis

Sureka B, Bansal K, Patidar Y, Rajesh S, Mukund A, Arora A.

Curr Probl Diagn Radiol. 2015 Sep-Oct;44(5):449-61. doi: 10.1067/j.cpradiol.2015.03.004. Epub 2015 Mar 20.

Association of the rs1801133 variant in the MTHFR gene and sporadic Parkinson's disease

García S, Coral-Vázquez R, Gallegos-Arreola MP, Montes-Almanza LA, Canto P, García-Martínez FA, Chavira-Hernández G, Palma-Flores C, Dávila-Maldonado L, Cuevas-García CF, López Hernández LB.

Folia Neuropathol. 2015;53(1):24-8. doi: 10.5114/fn.2015.49971.

Motor Performance Assessment in Parkinson's Disease: Association between Objective In-Clinic, Objective In-Home, and Subjective/Semi-Objective Measures

Toosizadeh N, Mohler J, Lei H, Parvaneh S, Sherman S, Najafi B.

PLoS One. 2015 Apr 24;10(4):e0124763. doi: 10.1371/journal.pone.0124763. eCollection 2015.

Clinical impact of gait training enhanced with visual kinematic biofeedback: Patients with Parkinson's disease and patients stable post stroke

Byl N, Zhang W, Coo S, Tomizuka M.

Neuropsychologia. 2015 Dec;79(Pt B):332-43. doi: 10.1016/j.neuropsychologia.2015.04.020. Epub 2015 Apr 22.

Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study

Mamikonyan E, Xie SX, Melvin E, Weintraub D.

Mov Disord. 2015 Jun;30(7):912-8. doi: 10.1002/mds.26236. Epub 2015 Apr 25.

Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases

Chin-Chan M, Navarro-Yepes J, Quintanilla-Vega B.

Front Cell Neurosci. 2015 Apr 10;9:124. doi: 10.3389/fncel.2015.00124. eCollection 2015.

Cucurbitacin E, An Experimental Lead Triterpenoid with Anticancer, Immunomodulatory and Novel Effects Against Degenerative Diseases. A Mini-Review

Attard E, Martinoli MG.

Curr Top Med Chem. 2015;15(17):1708-13. doi: 10.2174/1568026615666150427121331.

Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast

Popova B, Kleinknecht A, Braus GH.

Biomolecules. 2015 Apr 23;5(2):617-34. doi: 10.3390/biom5020617.

[Pay attention to researches on pain related to Parkinson's disease]

Liu C, Mao C.

Zhonghua Yi Xue Za Zhi. 2015 Feb 17;95(7):481-2.

Parkinsonism in a patient with Leber hereditary optic neuropathy (LHON)

Vital C, Julien J, Martin-Negrier ML, Lagueny A, Ferrer X, Vital A.

Rev Neurol (Paris). 2015 Sep;171(8-9):679-80. doi: 10.1016/j.neurol.2015.03.011. Epub 2015 Apr 24.

Vascular parkinsonism--characteristics, pathogenesis and treatment

Korczyn AD.

Nat Rev Neurol. 2015 Jun;11(6):319-26. doi: 10.1038/nrneurol.2015.61. Epub 2015 Apr 28.

Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease

Skorvanek M, Rosenberger J, Minar M, Grofik M, Han V, Groothoff JW, Valkovic P, Gdovinova Z, van Dijk JP.

J Neurol Sci. 2015;353(1-2):87-91. doi: 10.1016/j.jns.2015.04.013. Epub 2015 Apr 17.

Mental health and Parkinson's disease: from the cradle to the grave

Alamri YA.

Br J Gen Pract. 2015 May;65(634):258-9. doi: 10.3399/bjgp15X684985.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias